Treatment guided by detection of Minimal Residual Disease after allogeneic stem cell transplantation in Acute Myeloid Leukaemia.
Suspended
- Conditions
- AMLMRDAllogeneic stem cell transplantation
- Registration Number
- NL-OMON27188
- Lead Sponsor
- VU University medical center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 31
Inclusion Criteria
1. Patients with Acute Myeloid Leukemia according to WHO classification 2008;
2. Age 18-75;
Exclusion Criteria
1. Myelodysplastic syndrome with refractory anaemia with excess blasts (RAEB);
2. Acute Promyelocytic Leukemia (AML M3);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative incidence of (hematological) relapse.
- Secondary Outcome Measures
Name Time Method 1. Relapse free survival;<br /><br>2. Overall survival;<br /><br>3. Incidence of acute and chronic GVHD.